Overview
- 4 inspections across 4 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-20.
At a glance
Inspections
4
Sites
4
Observations
6
Career since
Dec 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Noble Life Sciences, Inc | 20 Jun 2025 | Biologics | View 483 → |
| NOBLE LIFE SCIENCES INC. | 20 Jun 2025 | Biologics | View 483 → |
| Samuel Parry, MD | 15 Dec 2022 | Human Drugs | |
| Eric C. Strain, MD | 7 Dec 2018 | Human Drugs |
Sites inspected
Noble Life Sciences, IncSykesville, United States1 insp.
NOBLE LIFE SCIENCES INC.Sykesville, United States1 insp.
Samuel Parry, MDPhiladelphia, United States1 insp.
Eric C. Strain, MDBaltimore, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Amanda M Szucsik2 shared
Hugh M Mcclure2 shared
Sam Pepe1 shared
Joseph L Despins1 shared
Miah Jung1 shared
David L Chon1 shared
Full investigator report
Get the verbatim findings behind Christine M Smith's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site